AI-powered, personalised ‘digital drugs’ are a reality now in health interventions.
SUNIL KUMAR, (name changed), a middle-aged IT professional from suburban Mumbai, found that he had high levels of blood sugar and symptoms of Type II diabetes after a routine blood test. The diabetologist prescribed a few medicines. But the last one jotted down after obtaining Kumar’s consent, took him by surprise. It was a mobile app called Wellthy Care.
The next day he got a call from Wellthy Therapeutics and soon, a kit with a blood glucose monitoring equipment and an ‘activation card’ was home-delivered. Since then, Wellthy is monitoring Kumar’s movements via his smartphone. If he orders a pizza from his mobile app or books a weekend movie ticket using his smartphone, he starts getting alerts on last week’s sugar levels and tips via chat on advisable food for the day and the week ahead. At times, the alert goes to his wife, Suma, advising her to include more salads and vegetables in Kumar’s lunchbox.
That is not all. If Kumar’s smartphone does not record any movement for hours, Carey, the personal health coach on the app, says, “Why don’t you talk to your client while walking to and fro to burn a few calories?” Despite being under constant surveillance, Kumar is happy. So are his family and his doctor. His food habits and health are going the way they want, and his sugar levels are under control.
Welcome to an all-new world of personalised, digital health care as Mumbai-based Wellthy Therapeutics claims to be India’s (and possibly South Asia’s) first and only ‘prescription digital therapeutics’ company.
What Is Digital Therapeutics
This story is from the August 12, 2018 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the August 12, 2018 edition of Business Today.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
"Attitude Decides Altitude"
BEST ADVICE - RAJNEET KOHLI, CEO & EXECUTIVE DIRECTOR, BRITANNIA INDUSTRIES LTD
"FOR RATAN TATA, IT WAS ALWAYS NATION FIRST"
Thomas Matthew, former IAS officer, on his new biography of Ratan Tata, the late Chairman Emeritus of Tata Sons
"RADICAL CHANGE NEEDED TO IMPROVE URBAN INFRA"
K.P. Singh, Chairman Emeritus of DLF, on the dynamic nature of the real estate sector, challenges in urban planning, and more
REDEFINING AMBITION
Shashikant Ruia was a visionary entrepreneur who navigated challenges with resilience. He leaves behind a rich legacy of ambition and leadership
ON THE WILD SIDE
LOVE WILDLIFE BUT DON'T WANT TO GIVE UP ON THE FINER THINGS WHILE ON A TRIP TO SPOT ANIMALS? CHECK OUT THESE LUXURIOUS WILDLIFE RESORTS FOR THE HOLIDAY SEASON
"India is the only market globally with substantial growth"
RHI Magnesita CEO Stefan Borgas on the company's M&A strategy, why India is important, the way ahead, and more
FRESH ON THE STREET
IPOs have come back with a bang in 2024, with a record ₹1.3 lakh crore raised till October. As a result, many newly-listed firms have made it to the BT500 list
RIDING THE WAVES
The shipping industry is on the brink of a transformation. Beyond government support and technological advancements, what are the other driving forces and emerging trends that will define the landscape in 2025?
HOME RUN
After a decade-long slowdown, India’s real estate market reached its highest decadal sales level in the first half of 2024
In Pursuit of Good Health
The past year has been eventful for the Indian pharma sector, with some companies witnessing growth, and some challenges. The outlook for the sector, however, remains positive